Publications

Incidence and prevalence

• Tuttle KR, Jones CR, Daratha KB, et al. Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015–2020. N Engl J Med. 2022;387(15):1430–1431. doi:10.1056/nejmc2207018.

• Burrows NR, Koyama A, Pavkov ME. Reported Cases of End-Stage Kidney Disease — United States, 2000–2019. MMWR Morb Mortal Wkly Rep. 2022;71(11):412–415. doi:10.15585/mmwr.mm7111a3.

• Oliver JD, Nee R, Grunwald LR, et al. Prevalence and Characteristics of CKD in the US Military Health System: A Retrospective Cohort Study. Kidney Med. 2022;4(7):100487. doi:10.1016/j.xkme.2022.100487.

Risk factors

• Piani F, Melena I, Tommerdahl KL, et al. Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications. J Diabetes Complications. 2021;35(4):107841. doi:10.1016/j.jdiacomp.2020.107841.

• Banerjee T, McCulloch CE, Crews DC, et al. Proinflammatory Diets and Risk of ESKD in US Adults with CKD. Kidney360. 2022;3(11):1852–1860. doi:10.34067/kid.0000442022.

• Banerjee T, Carrero JJ, McCulloch CE, et al. Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption. Am J Nephrol. 2021;52(5):356–367. doi:10.1159/000514754.

Disparities

• Chu CD, Powe NR, McCulloch CE, et al. Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019. JAMA Netw Open. 2021;4(9):e2127014. doi:10.1001/jamanetworkopen.2021.27014.

• Delgado C, Baweja M, Burrows NR, et al. Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force. J Am Soc Nephrol. 2021;32(6):1305–1317. doi:10.1681/asn.2021010039.

Outcomes and complications

• Harding JL, Pavkov ME, Wang Z, et al. Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA. BMJ Open Diabetes Res Care. 2021;9(1):e001962. doi:10.1136/bmjdrc-2020-001962.

• Burrows NR, Koyama AK, Choudhury D, et al. Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease. Am J Nephrol. 2022;53(8–9):652–662. doi:10.1159/000526254.

• Sohaney R, Yin H, Shahinian VB, et al. In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury. Clin J Am Soc Nephrol. 2022;17(2):184–193. doi:10.2215/cjn.01730221.

• Koyama AK, Lundeen EA, Bullard KM, Pavkov ME. Prevalence of anemia and associated All-Cause mortality among adults with Diabetes: The role of chronic kidney disease. Diabetes Res Clin Pract. 2023;200:110695. doi:10.1016/j.diabres.2023.110695.

Natural history

• Pauley ME, Vinovskis C, MacDonald A, et al. Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes. J Diabetes Complications. 2023;37(2):108384. doi:10.1016/j.jdiacomp.2022.108384.

• Melena I, Piani F, Tommerdahl KL, et al. Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study. J Diabetes Complications. 2022;36(6):108203. doi:10.1016/j.jdiacomp.2022.108203.

• Satake E, Saulnier PJ, Kobayashi H, et al. Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes. J Am Soc Nephrol. 2021;32(9):2331–2351. doi:10.1681/asn.2021010105.

• Vigers T, Vinovskis C, Li L, et al. Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes. Pediatr Nephrol. 2023;38(1):193–202. doi:10.1007/s00467-022-05531-3.

• Chu CD, Powe NR, McCulloch CE, et al. Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria. Hypertension. 2021;77(1):94–102. doi:10.1161/hypertensionaha.120.16281.